Related Experiment Video
Updated: Aug 30, 2025
08:31
Anaerobic Protein Purification and Kinetic Analysis via Oxygen Electrode for Studying DesB Dioxygenase Activity and Inhibition
Published on: October 3, 2018
8.6K
Does dexamethasone inhibit glucose oxidase: an analysis in kinetics and molecular study
Edris Majd1, Dariush Minai-Tehrani1, Hamidreza Mollasalehi1
1Faculty of Life Sciences and Biotechnology, Shahid Beheshti University (GC), Tehran, Iran.
Hormone Molecular Biology and Clinical Investigation
|August 31, 2022
Summary
Dexamethasone non-competitively inhibits glucose oxidase, an enzyme crucial for blood sugar testing kits. This drug interaction may lead to inaccurate glucose level readings in diabetic patients using these biosensors.
Area of Science:
- Biochemistry
- Enzymology
- Pharmacology
Background:
- Glucose oxidase, primarily from Aspergillus niger, is vital for blood glucose biosensors used by diabetics.
- Diabetes management involves addressing secondary conditions with medications like dexamethasone, a corticosteroid.
Purpose of the Study:
- To investigate the kinetic and molecular effects of dexamethasone on glucose oxidase.
- To understand the implications of this drug-enzyme interaction for diabetic blood glucose monitoring.
Main Methods:
- Enzyme kinetics analysis using Lineweaver-Burk plots to determine inhibition type and Ki value.
- Fluorescence spectrophotometry and molecular docking to confirm drug binding and elucidate binding site interactions.
Main Results:
- Dexamethasone was identified as a potent, non-competitive inhibitor of glucose oxidase.
- Drug binding induced conformational changes in the enzyme, leading to increased compaction.
- Molecular docking revealed dexamethasone binding outside the active site, stabilized by hydrogen bonds.
Conclusions:
- Dexamethasone's inhibition of glucose oxidase can cause inaccurate blood glucose readings in diabetic patients.
- This finding highlights the importance of considering drug interference in diagnostic biosensor accuracy.
